Always appreciate your contributions Marsman but with so many more shares in the market, the comparison in terms of value between now and prior to Phase 2 acne is probably better based upon market cap. Still a little ways to go for the current market to equate to previous highs but at roughly 240million we are getting fairly close, not sure if anyone can recall exactly but I thought BOT hit around 270 or 280.
I think Clinuvel might be a good comparison. ASX listed, single product for photosensitivity, a relatively rare skin condition with a few other irons in the research phase. Present market cap is just under 900million on revenue of 66million.
Always appreciate your contributions Marsman but with so many...
-
- There are more pages in this discussion • 4,520 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.8¢ |
Change
-0.003(0.69%) |
Mkt cap ! $647.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.3¢ | 35.5¢ | $1.314M | 3.604M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 116751 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 520217 | 13 |
View Market Depth
| Last trade - 15.26pm 23/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |